semaglutide olympia GLP-1 Agonists for Weight Loss OLYMPIA OR COMPOUNDED? : r/glp1

The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%

This is because their mechanism of action is glucose-dependent

Castellanos V, Workneh H, Malik A, et al

GLP injections are an effective medical option for those struggling with obesity or overweight, offering a combination of appetite suppression and improved metabolic functions

The key difference is that maintenance therapy is not about ongoing weight lossit is about preventing weight regain by continuing to modulate appetite-regulating hormones in the brain and gastrointestinal tract

GLP-1s increased the release of insulin but had an extremely short half-life (one to two minutes), making them highly unfavorable as a treatment for diabetes